During Michaelmas Term, OxTalks will be moving to a new platform (full details are available on the Staff Gateway).
For now, continue using the current page and event submission process (freeze period dates to be advised).
If you have any questions, please contact halo@digital.ox.ac.uk
Frances Edwards is Professor of Neurodegeneration at the Department of Neuroscience Physiology and Pharmacology, University College London.
Frances is also currently affiliated with the Editorial Boards of FEBS Letters and BMC Neuroscience, the Chair of Examiners for MSc Neuroscience at UCL, and is a Core member of Institute of Healthy Ageing at UCL.
Alzheimer’s disease is a devastating condition and its increasing prevalence in our ageing society imposes an increasing personal and financial burden. So far there is no treatment available to prevent, cure or delay its progression and this has become one of the most urgent challenges of our time. A major impediment to progress has been the lack of animal models in which rising amyloid beta leads to Tau pathology and consequent neurodegeneration. The models we have are however useful for understanding the earliest changes that occur as amyloid beta rises in the brain. In this seminar I present our results on the earliest synaptic changes and the interaction of amyloid pathology and the immune system in mouse models of Alzheimer’s disease. How do changes in mouse models relate to our knowledge of the human condition and how can we use this information to develop improved animal models?